Fact Sheet for Patients And Parent/Caregivers

Emergency Use Authorization (EUA) Of Remdesivir For Coronavirus Disease 2019 (COVID-19) by O'Horo, John C
 
 
 1 
Fact Sheet for Patients And Parent/Caregivers  
Emergency Use Authorization (EUA) Of Remdesivir  For Coronavirus Disease 2019 (COVID-19) 
 
You are being given a medicine called remdesivir for the treatment of coronavirus disease 2019 (COVID-19).  This 
fact sheet contains information to help you understand the risks and benefits of taking remdesivir, which you have 
received or may receive.   
 
There is no U.S. Food and Drug Administration (FDA) approved product available to treat COVID-19.  Receiving 
remdesivir may benefit certain people in the hospital with COVID-19.  Read this Fact Sheet for information about 
remdesivir.  Talk to your healthcare provider if you have questions.  It is your choice to receive remdesivir or stop 
it at any time. 
 
What is COVID-19? 
COVID-19 is caused by a virus called a coronavirus.  This type of coronavirus has not been seen before.  This 
new coronavirus was first found in people in Wuhan, Hubei Province, China in December 2019.  Person-to-
person spread was reported outside Hubei and in countries outside China, including in the United States.  
You can get COVID-19 through contact with another person who has the virus.   
 
COVID-19 illnesses have ranged from very mild (including some with no reported symptoms) to severe, including 
illness resulting in death.  While information so far suggests that most COVID-19 illness is mild, serious illness can 
happen and may cause some of your other medical conditions to become worse.  Older people and people of all 
ages with severe, long lasting (chronic) medical conditions like heart disease, lung disease and diabetes, for 
example, seem to be at higher risk of being hospitalized for COVID-19.   
 
What are the symptoms of COVID-19? 
The symptoms of COVID-19 are fever, cough, and shortness of breath, which may appear 2-14 days after exposure.  
Serious illness including breathing problems can occur and may cause your other medical conditions to become 
worse.  
    
What is remdesivir? 
Remdesivir is an investigational antiviral medicine to treat certain people in the hospital with COVID-19. Remdesivir 
is investigational because it is still being studied.  There is limited information known about the safety and 
effectiveness of using remdesivir to treat people in the hospital with COVID-19. Remdesivir was shown in a clinical 
trial to shorten the time to recovery in some people. There are no medicines approved by the FDA as safe and 
effective to treat people in the hospital who have COVID-19. Therefore, the FDA has authorized the emergency use 
of remdesivir for the treatment of COVID-19 under an Emergency Use Authorization (EUA). For more information on 
EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet.    
What should I tell my healthcare provider before I receive remdesivir? 
Tell your healthcare provider about all of your medical conditions, including if you: 
• Have any allergies  
• Have kidney or liver problems 
• Are pregnant or plan to become pregnant 
• Are breastfeeding or plan to breastfeed  
• Have any serious illnesses 
• Are taking any medicines (prescription, over-the-counter, vitamins, or herbal products) 
 
How will I receive remdesivir? 
Remdesivir is given to you through a vein (intravenous or IV) one time each day for up to 10 days depending on 
what your healthcare provider thinks is best for you.  Remdesivir may help decrease the amount of the coronavirus 
in your body.  This may help you to get better faster. 
  
 
What are the important possible side effects of remdesivir? 
Possible side effects of remdesivir are:  
• Infusion-related reactions. Infusion-related reactions have been seen during a remdesivir infusion or around the 
time remdesivir was given. Signs and symptoms of infusion-related reactions may include: low blood pressure, 
nausea, vomiting, sweating, and shivering. 
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• Increases in levels of liver enzymes. Increases in levels of liver enzymes have been seen in people who have 
received remdesivir, which may be a sign of inflammation or damage to cells in the liver. Your healthcare 
provider will do blood tests to check your liver before you receive remdesivir and daily while receiving 
remdesivir. 
 
These are not all the possible side effects of remdesivir.  Remdesivir is still being studied so it is possible that all of 
the risks are not known at this time. 
 
Not a lot of people have taken remdesivir.  Serious and unexpected side effects may happen.  The side effects of 
getting any medicine by vein may include brief pain, bleeding, bruising of the skin, soreness, swelling, and possible 
infection at the injection site. 
 
What other treatment choices are there? 
Like remdesivir, FDA may allow for the emergency use of other medicines to treat people in the hospital with 
COVID-19.  Go to www.cdc.gov/COVID19 for information on the emergency use of other medicines that are not 
approved by FDA to treat people in the hospital with COVID-19.  Your healthcare provider may talk with you about 
clinical trials you may be eligible for. 
 
It is your choice to be treated or not with remdesivir.  Should you decide not to receive it or stop it at any time, it will 
not change your standard medical care. 
 
What if I decide not to take remdesivir? 
If you do not take remdesivir, you might get sicker or even die.  Even if you receive remdesivir exactly as 
directed to treat COVID-19, there is still a chance you may get sicker or die. 
 
What if I am pregnant or breastfeeding? 
There is limited experience giving remdesivir to pregnant women or breastfeeding mothers.  For a mother and 
unborn baby, the benefit of receiving remdesivir may be greater than the risk from the treatment.  If you are 
pregnant or breastfeeding, discuss your options and specific situation with your healthcare provider. 
 
How do I report side effects with remdesivir? 
Tell your healthcare provider right away if you have any side effect that bothers you or does not go away.  
 
Report side effects to FDA MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088. 
 
How can I learn more? 
• Ask your healthcare provider. 
• Visit http://www.cdc.gov/COVID19   
• Contact your local or state public health department. 
 
What is an Emergency Use Authorization (EUA)? 
 
The United States FDA has made remdesivir available under an emergency access mechanism called an EUA. 
The EUA is supported by a Secretary of Health and Human Service (HHS) declaration that circumstances exist to 
justify the emergency use of drugs and biological products during the COVID-19 pandemic.  
 
Remdesivir has not undergone the same type of review as an FDA-approved or cleared product. FDA may issue 
an EUA when certain criteria are met, which includes that there are no adequate, approved, available alternatives. 
In addition, the FDA decision is based on the totality of scientific evidence available showing that it is reasonable 
to believe that the product meets certain criteria for safety, performance, and labeling and may be effective in 
treatment of patients during the COVID-19 pandemic. All of these criteria must be met to allow for the product to 
be used in the treatment of patients during the COVID-19 pandemic.  
 
The EUA for remdesivir is in effect for the duration of the COVID-19 declaration justifying emergency use of these 
products, unless terminated or revoked (after which the products may no longer be used). 
